Clinical trial
Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
NCT00004826 is registered in ClinicalTrials.gov with Memorial Hospital of Rhode Island as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
- Lead sponsor
- Memorial Hospital of Rhode Island
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 1993
- Completion date
- November 30, 1997
- Enrollment
- 60
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.